Insider dealing case begins over Novartis buyout

A FINANCE director and two lawyers appeared in court yesterday charged with eight counts of insider dealing during the £305m takeover of a biotech firm NeuTec Pharma by Swiss giant drugmaker Novartis in 2006.
Andrew King, 62, is charged with disclosing inside information about the takeover of NeuTec Pharma, which he was party to as the firm’s finance director, to 43-year-old lawyer Michael McFall. McFall is alleged to have then passed this information on to law partner Andrew Rimmington.